EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access

Mitochondrial Dysfunction and Bioenergetics in Chronic Obstructive Pulmonary Disease: Mechanisms, Biomarkers, and Therapeutic Opportunities

Rishit Bhat iD, Liam B Dunne, Sophia Miles, Ahmad Kazi, Daniyal Siddiqui, Mutahhar N Warriach, Chibudom T Ofoegbu, Zaid Vellani iD

The Yale Journal of Biology and Medicine · 2026-11-04 · 99 (3) · 547-557

DOI: 10.59249/uvmv3274 ↗

At a glance

Übersichtsarbeit in The Yale Journal of Biology and Medicine, published online on 2026-11-04. Written by Rishit Bhat and 7 co-authors. Institution: Molecular, Cell, and Developmental Biology University of California, Los Angeles. Major MEDLINE topics: Pulmonary Disease, Chronic Obstructive, Mitochondria, Biomarkers, Energy Metabolism. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms and persistent obstruction of airflow arising from abnormalities of the airways and/or alveoli. Its pathogenesis includes multiple interacting exposures and susceptibilities, including cigarette smoking, biomass and occupational exposures, air pollution, and genetic factors. Per this paradigm, researchers have historically focused on developing broad anti-inflammatory therapeutics that manage acute symptoms but fail to arrest progressive decline. Within this heterogeneous disease framework, mitochondrial dysfunction may contribute to chronic obstructive pulmonary disease pathobiology through interactions with oxidative stress, inflammation, impaired quality control, and altered cellular bioenergetics. We evaluate mitochondrial-associated biomarkers for disease severity, progression, and patient stratification, while considering their limited specificity and susceptibility to confounding by aging and comorbidities. We also assess the limitations of broad-spectrum antioxidant strategies and examine mitochondrial-targeted antioxidants and metabolic modulators, such as SS-31, MitoQ, and metformin. In addition, the review examines emerging mitochondrial stress pathways, including OMA1-DELE1-HRI signaling, while emphasizing that their direct involvement in chronic obstructive pulmonary disease remains unestablished. Altogether, the evidence available supports mitochondrial biology as a complementary area of investigation within the broader inflammatory, structural, and metabolic heterogeneity of chronic obstructive pulmonary disease, while our review reveals that substantial mechanistic and clinical validation remains necessary.

Subjects

MeSH terms (MEDLINE)

Pulmonary Disease, Chronic ObstructiveMitochondriaBiomarkersEnergy MetabolismHumansOxidative StressAntioxidantsAnimals

Author keywords

biomarkerschronic obstructive pulmonary disease (COPD)metabolic reprogrammingmitochondrial dysfunctionmitochondrial-targeted antioxidantsoxidative stressreactive oxygen species

Substances

BiomarkersAntioxidants

Authors and institutions

  • Molecular, Cell, and Developmental Biology University of California, Los Angeles.
  • Computational and Systems Biology University of California, Los Angeles.
  • Mathematics University of California, Los Angeles.
  • Integrative Biology and Physiology University of California, Los Angeles.
  • Physiology and Medical Sciences University of Arizona, Tucson.
  • Psychology University of California, Los Angeles.

ORCID profiles: Rishit Bhat, Zaid Vellani

Cite

APA

Bhat, R., Dunne, L. B., Miles, S., Kazi, A., Siddiqui, D., Warriach, M. N., Ofoegbu, C. T., & Vellani, Z. (2026). Mitochondrial Dysfunction and Bioenergetics in Chronic Obstructive Pulmonary Disease: Mechanisms, Biomarkers, and Therapeutic Opportunities. The Yale Journal of Biology and Medicine, 99(3), 547-557. https://doi.org/10.59249/uvmv3274

Vancouver

Bhat R, Dunne LB, Miles S, Kazi A, Siddiqui D, Warriach MN, et al. Mitochondrial Dysfunction and Bioenergetics in Chronic Obstructive Pulmonary Disease: Mechanisms, Biomarkers, and Therapeutic Opportunities. The Yale Journal of Biology and Medicine. 2026;99(3):547-557. doi:10.59249/uvmv3274

BibTeX
@article{Bhat2026,
  author = {Bhat, Rishit and Dunne, Liam B and Miles, Sophia and Kazi, Ahmad and Siddiqui, Daniyal and Warriach, Mutahhar N and Ofoegbu, Chibudom T and Vellani, Zaid},
  title = {Mitochondrial Dysfunction and Bioenergetics in Chronic Obstructive Pulmonary Disease: Mechanisms, Biomarkers, and Therapeutic Opportunities},
  journal = {The Yale Journal of Biology and Medicine},
  year = {2026},
  volume = {99},
  number = {3},
  pages = {547--557},
  doi = {10.59249/uvmv3274}
}
Start for free →